| Abiy D Mekoya, MD | |
|
1350 Walton Way, Augusta, GA 30901-2612 | |
| (706) 774-5795 | |
| (706) 774-7230 |
| Full Name | Abiy D Mekoya |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 1350 Walton Way, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023064938 | NPI | - | NPPES |
| 34698100 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 47598 (Wisconsin) | Secondary |
| 207R00000X | Internal Medicine | 58369 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of Macon | Macon, GA | Home health agency |
| University Hospital | Augusta, GA | Hospital |
| Phoebe Sumter Medical Center | Americus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Physician Services - Southeast Professional Corporation | 5597774554 | 640 |
| Phoebe Physician Group Inc | 8426112350 | 342 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | 24 On Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956251 PECOS PAC ID: 5698688141 Enrollment ID: O20031216000444 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | Cogent Healthcare Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609827823 PECOS PAC ID: 2961483607 Enrollment ID: O20040527000856 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | Nes Georgia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144201559 PECOS PAC ID: 0345210001 Enrollment ID: O20040729000602 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20060419000545 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | East Georgia Internal Medicine ,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194835280 PECOS PAC ID: 9133128598 Enrollment ID: O20061212000447 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | Phoebe Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487899464 PECOS PAC ID: 8426112350 Enrollment ID: O20090121000583 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | Erx Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760823082 PECOS PAC ID: 9335037571 Enrollment ID: O20130930000326 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Entity Name | Anemonefish Inpatient Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033514716 PECOS PAC ID: 7012236664 Enrollment ID: O20150501001344 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abiy D Mekoya, MD Po Box 1705, Augusta, GA 30903-1705 Ph: (706) 774-7263 | Abiy D Mekoya, MD 1350 Walton Way, Augusta, GA 30901-2612 Ph: (706) 774-5795 |
News Archive
People admitted to English hospitals in an emergency on the first Wednesday in August have, on average, a six percent higher mortality rate than people admitted on the previous Wednesday, according to research published in PLoS One today.
Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of the intravenous (IV) dosage form of torezolid phosphate, an IV and orally administered second generation oxazolidinone for the treatment of serious gram positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.
› Verified 8 days ago
Dr. Bryan Richard Broach, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 | |
Dr. Kayla Ashley Shahbazian, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 Fax: 706-721-1459 | |
Dr. Harvey Schwartz, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2273 | |
Dr. Anam Asif Herekar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2423 | |
Dr. Robert Allen Price, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 Magnolia Way Ste 101, Augusta, GA 30909 Phone: 706-922-6600 Fax: 706-650-0239 | |
Matthew Kevin Howard, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 818 Saint Sebastian Way, Suite 311, Augusta, GA 30901 Phone: 706-724-3473 | |
Enoch Busulwa Lule, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 Walton Way, Augusta, GA 30901 Phone: 706-774-5542 Fax: 706-774-5789 |